At a glance
ClinicalIndex Comparison RecordN/ACompleted· 571 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
In Brief
An observational study for Restless Legs Syndrome. Completed, enrolled 571 participants across 159 sites.
Detailed Summary
The survey is conducted to investigate the safety and efficacy of long-term use of BI-Sifrol Tablets in Restless Legs Syndrome (RLS) patients with or without renal dysfunction in routine medical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRestless Legs Syndrome
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedAug 2010
Primary CompletionAug 2013
TodayJul 2026
First PostedAug 3, 2010
Enrollment StartAug 1, 2010
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 15.9 years ago